Aspen Aerogels (ASPN) Misses Q3 EPS by 4c; Trims Outlook

November 4, 2016 6:18 AM EDT

Get access to the best calls on Wall Street with's Ratings Insider Elite. Get your Free Trial here.

Aspen Aerogels (NYSE: ASPN) reported Q3 EPS of ($0.13), $0.04 worse than the analyst estimate of ($0.09). Revenue for the quarter came in at $29.6 million versus the consensus estimate of $29.05 million.


Aspen Aerogels sees FY2016 EPS of ($0.46)-($0.41), versus prior guidance of ($0.37)-($0.30) and the consensus of ($0.31). Aspen Aerogels sees FY2016 revenue of $118-121 million, versus prior guidance of $117-125 million and the consensus of $120.0 million.

For earnings history and earnings-related data on Aspen Aerogels (ASPN) click here.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Earnings, Guidance

Related Entities


Add Your Comment